Brief: Cytek Biosciences Q3 Revenue USD 53.229 Million
BRIEF-Cytek Biosciences Q3 Revenue USD 53.229 Million Nov 04 (Reuters) - Cytek Biosciences Q3 pretax profit USD -6.908 million.
- Q3 adjusted EBITDA USD 711 thousand
- Q3 net income USD -6.097 million
- outlook FY revenue USD 208-211 million
Recent news on Cytek Biosciences
See all newsCytek Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
Cytek Biosciences Q3 revenue rises 2% on US growth
Brief: Cytek Biosciences Q3 Revenue USD 53.229 Million
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says